Schrödinger teams up with MD An­der­son on WEE1 in­hibitor pro­gram; Amid JAK safe­ty con­cerns, Ab­b­Vie touts new da­ta for Rin­voq 

Physics-based dis­cov­ery out­fit Schrödinger and the Uni­ver­si­ty of Texas MD An­der­son Can­cer Cen­ter an­nounced to­day a two-year re­search col­lab­o­ra­tion — fo­cused on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA